The Clinical Operations team at Asklepios BioPharmaceutical is responsible for overseeing the planning, execution, and management of clinical trials for AAV gene therapies targeting neurodegenerative and rare diseases. This team collaborates with various stakeholders to ensure compliance with regulatory standards, manages trial logistics, and analyzes data to drive the development of innovative treatments, ultimately aiming to improve patient outcomes.
View all